Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin

Podobne zapisy

• Fatty liver in uncomplicated type 2 DM is associated with impaired myocardial HEP metabolism, modulated by myocardial glucose uptake
  od: Jonker, Jacqueline T, i wsp.
  Wydane: (2009)
• Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes
  od: Jonker, Jacqueline T., i wsp.
  Wydane: (2010)
• Liver Fat Content in Type 2 Diabetes: Relationship With Hepatic Perfusion and Substrate Metabolism
  od: Rijzewijk, Luuk J., i wsp.
  Wydane: (2010)
• Right ventricular function and dimensions in type 2 diabetes mellitus
  od: Widya, Ralph, i wsp.
  Wydane: (2012)
• Right Ventricular Involvement in Diabetic Cardiomyopathy
  od: Widya, Ralph L., i wsp.
  Wydane: (2013)